View : 281 Download: 0
The Skin Antiseptic agents at Vaginal dElivery (SAVE) trial: study protocol for a randomized controlled trial
- Title
- The Skin Antiseptic agents at Vaginal dElivery (SAVE) trial: study protocol for a randomized controlled trial
- Authors
- Jung; Young Mi; Lee; Seung Mi; Kim; So Yeon; Chung; Jin Hoon; Won; Hye-Sung; Kyung A; Park; Mi Hye; Cho; Geum Joon; Oh; Min-Jeong; Choi; Eun Saem; Ahn; Ki Hoon; Hong; Soon-Cheol; Sung; Ji-Hee; Roh; Cheong-Rae; Sun Min; Byoung Jae; Hyeon Ji; Kyung Joon; Subeen; In Yang; Joong Shin
- Ewha Authors
- 박미혜; 이경아
- SCOPUS Author ID
- 박미혜; 이경아
- Issue Date
- 2023
- Journal Title
- Trials
- ISSN
- 1745-6215
- Citation
- Trials vol. 24, no. 1
- Keywords
- Antiseptic; Perineal infection; Randomized controlled trial; Vaginal delivery
- Publisher
- BioMed Central Ltd
- Indexed
- SCIE; SCOPUS
- Document Type
- Article
- Abstract
- Background: Cleansing of the vulva and perineum is recommended during preparation for vaginal delivery, and special attention is paid to cleansing before episiotomy because episiotomy is known to increase the risk of perineal wound infection and/or dehiscence. However, the optimal method of perineal cleansing has not been established, including the choice of antiseptic agent. To address this issue, we designed a randomized controlled trial to examine whether skin preparation with chlorhexidine-alcohol is superior to povidone-iodine for the prevention of perineal wound infection after vaginal delivery. Methods: In this multicenter randomized controlled trial, term pregnant women who plan to deliver vaginally after episiotomy will be enrolled. The participants will be randomly assigned to use antiseptic agents for perineal cleansing (povidone-iodine or chlorhexidine-alcohol). The primary outcome is superficial or deep perineal wound infection within 30 days after vaginal delivery. The secondary outcomes are the length of hospital stay, physician office visits, or hospital readmission for infection-related complications, endometritis, skin irritations, and allergic reactions. Discussion: This study will be the first randomized controlled trial aiming to determine the optimal antiseptic agent for the prevention of perineal wound infections after vaginal delivery. Trial registration: ClinicalTrials.gov NCT05122169. First submitted date on 8 November 2021. First posted date on 16 November 2021 © 2023, The Author(s).
- DOI
- 10.1186/s13063-023-07101-w
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML